The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Qsemble Capital Management LP

Qsemble Capital Management LP reduced its position in The Cooper Companies, Inc. (NASDAQ:COO) by 85.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,666 shares of the medical device company’s stock after selling 40,049 shares during the period. Qsemble Capital Management LP’s holdings in Cooper Companies were worth $736,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in COO. Innealta Capital LLC acquired a new stake in Cooper Companies in the second quarter valued at approximately $25,000. Ashton Thomas Securities LLC purchased a new position in shares of Cooper Companies during the 3rd quarter valued at approximately $25,000. Crewe Advisors LLC grew its stake in Cooper Companies by 286.4% in the 2nd quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock valued at $30,000 after acquiring an additional 252 shares during the period. Tortoise Investment Management LLC increased its holdings in Cooper Companies by 75.4% in the 2nd quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company’s stock worth $34,000 after acquiring an additional 169 shares in the last quarter. Finally, Covestor Ltd raised its position in Cooper Companies by 144.9% during the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after acquiring an additional 200 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Up 0.2 %

Cooper Companies stock opened at $102.64 on Wednesday. The stock’s fifty day moving average is $105.74 and its two-hundred day moving average is $98.39. The stock has a market cap of $20.44 billion, a PE ratio of 57.18, a P/E/G ratio of 2.17 and a beta of 0.99. The Cooper Companies, Inc. has a 1-year low of $82.21 and a 1-year high of $112.38. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.18.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The firm had revenue of $1 billion during the quarter, compared to analysts’ expectations of $997.30 million. During the same quarter in the previous year, the business earned $0.84 earnings per share. The firm’s revenue was up 7.8% compared to the same quarter last year. On average, sell-side analysts expect that The Cooper Companies, Inc. will post 3.65 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently issued reports on COO. Wells Fargo & Company lifted their price objective on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $115.00 price target (up from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Piper Sandler increased their price objective on Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Finally, Robert W. Baird increased their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research report on Thursday, August 29th. Four equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat.com, Cooper Companies currently has a consensus rating of “Moderate Buy” and an average target price of $117.00.

Insider Transactions at Cooper Companies

In related news, CAO Agostino Ricupati sold 1,601 shares of the company’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total value of $172,956.03. Following the completion of the sale, the chief accounting officer now directly owns 4,818 shares of the company’s stock, valued at $520,488.54. This represents a 24.94 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Brian G. Andrews sold 24,788 shares of Cooper Companies stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $105.90, for a total value of $2,625,049.20. Following the transaction, the chief financial officer now directly owns 6,614 shares in the company, valued at approximately $700,422.60. This trade represents a 78.94 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 256,373 shares of company stock worth $27,637,427. 2.00% of the stock is currently owned by insiders.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.